CIK: 0001535610
Total reported value
$45.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ishares Tr | Stock-Other | 18.64% | — | — | |
| 2 | ✓ | Esperion Therapeutics INC Ne | Stock-Other | 12.61% | — | +26.52% | |
| 3 | BIIB | Biogen INC | Stock-Healthcare | 12.27% | — | +254.52% | |
| 4 | ✓ | Spdr Series Trust | Stock-Other | 7.48% | — | +496.11% | |
| 5 | SRPT | Sarepta Therapeutics, Inc. | Stock-Healthcare | 6.17% | — | — | |
| 6 | ✓ | Odonate Therapeu | Stock-Other | 4.65% | — | -1.06% | |
| 7 | AZN | AstraZeneca PLC | Stock-Healthcare | 4.07% | — | -8.13% | |
| 8 | ✓ | Sarepta Therapeutics INC | Stock-Other | 3.05% | — | -4.85% | |
| 9 | ESPR | Esperion Therapeutics INC | Stock-Other | 2.07% | — | +38.45% | |
| 10 | ✓ | Amarin Corp PLC | Stock-Other | 1.97% | — | -54.62% | |
| 11 | AZN | AstraZeneca PLC | Stock-Healthcare | 1.83% | — | -61.23% | |
| 12 | ✓ | Spdr Series Trust | Stock-Other | 1.61% | — | -63.07% | |
| 13 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 1.45% | — | — | |
| 14 | ✓ | Stock-Other | 1.37% | — | -36.63% | ||
| 15 | ✓ | Stock-Other | 1.21% | — | +439.29% | ||
| 16 | ✓ | Zogenix INC | Stock-Other | 1.17% | — | -62.43% | |
| 17 | BCLIEUR | Brainstorm Cell Therapeutics | Stock-Other | 1.16% | — | +11.44% | |
| 18 | XERS | Xeris Biopharma Holdings, Inc. | Stock-Other | 1.12% | — | -58.33% | |
| 19 | ORMP | Oramed Pharmaceuticals INC | Stock-Other | 0.91% | — | +16.45% | |
| 20 | ✓ | Stock-Other | 0.87% | — | -82.56% | ||
| 21 | NKTREUR | Nektar Therapeutics | Stock-Other | 0.84% | — | -73.29% | |
| 22 | ✓ | Ophthotech Corporation | Stock-Other | 0.79% | — | +25.86% | |
| 23 | ✓ | Stock-Other | 0.75% | — | +11.64% | ||
| 24 | ✓ | Stock-Other | 0.69% | — | +9.80% | ||
| 25 | FGENEUR | Fibrogen INC | Stock-Other | 0.68% | — | +277.88% | |
| 26 | ✓ | Unum Therapeutics INC | Stock-Other | 0.64% | — | -17.47% | |
| 27 | MDGL | Madrigal Pharmaceuticals, Inc. | Stock-Healthcare | 0.56% | — | — | |
| 28 | ✓ | Aveo Pharmaceuticals INC | Stock-Other | 0.56% | — | -11.91% | |
| 29 | ✓ | Outlook Therapeutics INC | Stock-Other | 0.45% | — | — | |
| 30 | ✓ | Pavmed INC | Stock-Other | 0.41% | — | +101.52% | |
| 31 | ✓ | Amarin Corp PLC | Stock-Other | 0.37% | — | — | |
| 32 | ✓ | Spdr S&p 500 ETF Tr | ETF-Large Cap & Growth | 0.35% | +30.26% | +7.55% | |
| 33 | ✓ | Sangamo Therapeutics INC | Stock-Other | 0.30% | — | +2519.79% | |
| 34 | ✓ | Stock-Other | 0.30% | — | +13.51% | ||
| 35 | SLNOEUR | Soleno Therapeutics INC | Stock-Other | 0.29% | — | -29.84% | |
| 36 | BIIB | Biogen Inc. | Stock-Healthcare | 0.29% | — | — | |
| 37 | CYTREUR | Cytrx CORP | Stock-Other | 0.27% | — | +46.16% | |
| 38 | ✓ | Ability INC | Stock-Other | 0.22% | — | — | |
| 39 | ISREUR | Isoray INC | Stock-Other | 0.22% | — | +17.10% | |
| 40 | ✓ | Tonix Pharmaceuticals Holdin | Stock-Other | 0.21% | — | — | |
| 41 | ABTUGBX | Aquabounty Technologies | Stock-Other | 0.21% | — | — | |
| 42 | ✓ | Viking Therapeutics INC | Stock-Other | 0.20% | — | +13344.44% | |
| 43 | ✓ | Theriva Biologics INC Com New | Stock-Other | 0.20% | — | — | |
| 44 | MKGIDEUR | Monaker Group INC | Stock-Other | 0.20% | — | +14.81% | |
| 45 | ✓ | Magenta Therapeutics INC | Stock-Other | 0.20% | — | +13.72% | |
| 46 | ✓ | Rewalk Robotics LTD | Stock-Other | 0.18% | — | — | |
| 47 | ✓ | Medigus LTD | Stock-Other | 0.17% | — | -17.69% | |
| 48 | ✓ | Phio Pharmaceuticals CORP | Stock-Other | 0.17% | — | — | |
| 49 | ATOSEUR | Atossa Therapeutics INC | Stock-Other | 0.17% | — | +8.04% | |
| 50 | NUROEUR | Neurometrix INC | Stock-Other | 0.16% | — | +78.11% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Spdr S&p 500 ETF Tr | +8.8% | +7.55% | Add |
| 2 | BIIB | Biogen INC | +6.7% | +254.52% | Add |
| 3 | ✓ | Esperion Therapeutics INC Ne | +4.8% | +26.52% | Add |
| 4 | ✓ | Spdr Series Trust | +4.4% | +496.11% | Add |
| 5 | ✓ | Odonate Therapeu | +1.9% | -1.06% | Trim |
| 6 | AZN | AstraZeneca PLC | +0.9% | -8.13% | Trim |
| 7 | ESPR | Esperion Therapeutics INC | +0.8% | +38.45% | Add |
| 8 | ✓ | +0.7% | +439.29% | Add | |
| 9 | SRPT | Sarepta Therapeutics, Inc. | +0.6% | — | Unchanged |
| 10 | BIIB | Biogen Inc. | +0.5% | -27.70% | Trim |
| 11 | FGENEUR | Fibrogen INC | +0.4% | +277.88% | Add |
| 12 | ✓ | Sarepta Therapeutics INC | +0.2% | -4.85% | Trim |
| 13 | ORMP | Oramed Pharmaceuticals INC | +0.1% | +16.45% | Add |
| 14 | ✓ | +0.1% | +11.64% | Add | |
| 15 | ✓ | Ophthotech Corporation | +0.1% | +25.86% | Add |
| 16 | ✓ | 0% | +9.80% | Add | |
| 17 | MDGL | Madrigal Pharmaceuticals, Inc. | 0% | — | Unchanged |
| 18 | SGMOQ | Sangamo Therapeutics INC | -0.1% | -99.47% | Trim |
| 19 | ✓ | Aveo Pharmaceuticals INC | -0.1% | -11.91% | Trim |
| 20 | ✓ | Marinus Pharmaceuticals INC | -0.2% | -82.01% | Trim |
| 21 | ✓ | -0.2% | -36.63% | Trim | |
| 22 | ✓ | Unum Therapeutics INC | -0.3% | -17.47% | Trim |
| 23 | XERS | Xeris Biopharma Holdings, Inc. | -0.3% | -58.33% | Trim |
| 24 | ✓ | Sangamo Therapeutics INC | -0.5% | +2519.79% | Add |
| 25 | AZN | AstraZeneca PLC | -0.7% | -61.23% | Trim |
| 26 | ✓ | Amarin Corp PLC | -0.7% | -54.62% | Trim |
| 27 | ✓ | Zogenix INC | -0.9% | -62.43% | Trim |
| 28 | ✓ | Spdr Series Trust | -1.2% | -63.07% | Trim |
| 29 | ZSANEUR | Zosano Pharma CORP | -1.5% | -33.25% | Trim |
| 30 | NKTREUR | Nektar Therapeutics | -1.7% | -73.29% | Trim |
| 31 | ✓ | -3.1% | -82.56% | Trim | |
| 32 | SPY | State Street SPDR S&P 500 ETF Trust | — | EXIT | Sold out |
| 33 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 34 | ✓ | Ishares Tr | — | NEW | New buy |
| 35 | ✓ | Ishares Tr | — | EXIT | Sold out |
| 36 | ✓ | — | EXIT | Sold out | |
| 37 | ✓ | Viking Therapeutics INC | — | EXIT | Sold out |
| 38 | ✓ | Fibrogen INC | — | EXIT | Sold out |
| 39 | ✓ | Global Blood Therapeutics INC | — | EXIT | Sold out |
| 40 | XBI | Ss Spdr S&p Biotech ETF | — | NEW | New buy |
| 41 | ✓ | Oncobiologics INC | — | EXIT | Sold out |
| 42 | VKTX | Viking Therapeutics INC | — | EXIT | Sold out |
| 43 | ✓ | Amicus Therapeutics INC | — | EXIT | Sold out |
| 44 | ✓ | Alkermes PLC | — | EXIT | Sold out |
| 45 | ✓ | Amicus Therapeutics INC | — | EXIT | Sold out |
| 46 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 47 | ✓ | Outlook Therapeutics INC | — | NEW | New buy |
| 48 | ✓ | Adverum Biotechnologies INC | — | EXIT | Sold out |
| 49 | ✓ | Aptinyx INC | — | EXIT | Sold out |
| 50 | ✓ | Amarin Corp PLC | — | NEW | New buy |